These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 16046488)

  • 21. [Serotonin syndrome associated with the administration of duloxetine; report of a case].
    Fernández Fernández R; Fernández Alonso E; Castro Rebollo P; Soy Muner D
    Farm Hosp; 2016 May; 40(3):225-6. PubMed ID: 27145391
    [No Abstract]   [Full Text] [Related]  

  • 22. Combination of lithium and duloxetine in 2 depressed patients refractory to duloxetine monotherapy.
    Steffenhagen N; Kürstein B; Kirkby KC; Himmerich H
    Pharmacopsychiatry; 2011 Mar; 44(2):72-4. PubMed ID: 21161884
    [No Abstract]   [Full Text] [Related]  

  • 23. High-dose duloxetine for treatment-resistant obsessive-compulsive disorder: a case report with sustained full remission.
    Yeh YW; Chen CH; Kuo SC; Wang SC; Chen CK; Feng HM
    Clin Neuropharmacol; 2009; 32(3):174-6. PubMed ID: 19483491
    [No Abstract]   [Full Text] [Related]  

  • 24. Duloxetine--three birds with one stone?
    Michel MC
    Int J Clin Pract; 2007 Aug; 61(8):1247-8. PubMed ID: 17627705
    [No Abstract]   [Full Text] [Related]  

  • 25. [Dual acting reuptake inhibitors in the treatment of depression and pain].
    Hajak G
    Dtsch Med Wochenschr; 2006 Dec; 131 Suppl 8():S280-3. PubMed ID: 17139587
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The treatment of urinary incontinence with Duloxetine.
    Basu M; Duckett J
    J Obstet Gynaecol; 2008 Feb; 28(2):166-9. PubMed ID: 18393011
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prescribing update: why choose duloxetine for depression?
    Tobin ML
    Issues Ment Health Nurs; 2007 Jan; 28(1):117-20. PubMed ID: 17130011
    [No Abstract]   [Full Text] [Related]  

  • 28. An open-label study of duloxetine hydrochloride, a mixed serotonin and noradrenaline reuptake inhibitor, in patients with DSM-III-R major depressive disorder. Lilly Duloxetine Depression Study Group.
    Berk M; du Plessis AD; Birkett M; Richardt D
    Int Clin Psychopharmacol; 1997 May; 12(3):137-40. PubMed ID: 9248869
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serotonin-norepinephrine reuptake inhibitor treatment for tinnitus and depression.
    Chang JP; Wu CC
    J Clin Psychopharmacol; 2012 Oct; 32(5):729. PubMed ID: 22926618
    [No Abstract]   [Full Text] [Related]  

  • 30. Efficacy of duloxetine and selective serotonin reuptake inhibitors: comparisons as assessed by remission rates in patients with major depressive disorder.
    Thase ME; Pritchett YL; Ossanna MJ; Swindle RW; Xu J; Detke MJ
    J Clin Psychopharmacol; 2007 Dec; 27(6):672-6. PubMed ID: 18004135
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Duloxetine treatment of social anxiety disorder with comorbid major depression.
    Lin CC
    J Clin Psychopharmacol; 2008 Oct; 28(5):591-2; author reply 592-3. PubMed ID: 18794669
    [No Abstract]   [Full Text] [Related]  

  • 32. Is there a place for duloxetine?
    Drug Ther Bull; 2007 Apr; 45(4):29-32. PubMed ID: 17451072
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recurrent episodes of serotonin-reuptake inhibitor-mediated hyponatremia in an elderly patient.
    Stovall R; Brahm NC; Crosby KM
    Consult Pharm; 2009 Oct; 24(10):765-8. PubMed ID: 20017411
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Duloxetine related hypersexuality: a case report.
    Lai CH
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Mar; 34(2):414-5. PubMed ID: 19945494
    [No Abstract]   [Full Text] [Related]  

  • 35. Successful duloxetine treatment of a binge eating disorder: a case report.
    Bernardi S; Pallanti S
    J Psychopharmacol; 2010 Aug; 24(8):1269-72. PubMed ID: 19010975
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Duloxetine is effective in treating depression in multiple sclerosis patients: an open-label multicenter study.
    Solaro C; Bergamaschi R; Rezzani C; Mueller M; Trabucco E; Bargiggia V; Dematteis F; Mattioda A; Cimino V; Restivo D; Patti F; Cavalla P
    Clin Neuropharmacol; 2013; 36(4):114-6. PubMed ID: 23783007
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Successful treatment of refractory hypochondriasis with duloxetine.
    Politi P; Emanuele E
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1145-6. PubMed ID: 17493731
    [No Abstract]   [Full Text] [Related]  

  • 38. The influence of smoking on the serum level of duloxetine.
    Fric M; Pfuhlmann B; Laux G; Riederer P; Distler G; Artmann S; Wohlschläger M; Liebmann M; Deckert J
    Pharmacopsychiatry; 2008 Jul; 41(4):151-5. PubMed ID: 18651344
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined use of ECT with duloxetine and olanzapine: a case report.
    Hanretta AT; Malek-Ahmadi P
    J ECT; 2006 Jun; 22(2):139-41. PubMed ID: 16801831
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Successful duloxetine use to prevent venlafaxine withdrawal symptoms.
    Hsiao MC; Liu CY
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):576. PubMed ID: 17889418
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.